Related Experiment Videos
Stable, soluble T-cell receptor molecules for crystallization and therapeutics
Jonathan M Boulter1, Meir Glick, Penio T Todorov
1Avidex Ltd. 57 Milton Park, Abingdon, Oxon OX14 4RX, UK.
Protein Engineering
|October 16, 2003
Summary
Researchers engineered soluble T-cell receptors (TCRs) for improved characterization and potential therapeutic use. This overcomes challenges in producing stable, soluble TCRs, unlike antibodies.
Area of Science:
- Immunology
- Structural Biology
- Protein Engineering
Background:
- Antibody and T-cell receptors (TCRs) are key recognition molecules in adaptive immunity.
- Soluble antibodies are well-characterized and widely used therapeutically.
- TCRs are cell-surface anchored, hindering their characterization and therapeutic development.
Purpose of the Study:
- To engineer soluble human TCRs for enhanced characterization.
- To develop TCRs suitable for crystallization studies.
- To explore potential in vivo therapeutic applications of soluble TCRs.
Main Methods:
- Protein engineering strategies were employed to modify human TCRs.
- Focus on removing the trans-membrane domain to achieve solubility.
- Assessment of protein stability and suitability for structural analysis.
Main Results:
- Successfully engineered stable, soluble human TCRs.
- The engineered TCRs are suitable for crystallization.
- Demonstrated a method to overcome previous limitations in TCR production.
Conclusions:
- The engineered soluble TCRs represent a significant advancement for TCR research.
- This breakthrough facilitates structural studies and opens avenues for TCR-based therapeutics.
- The developed method addresses the long-standing challenge of producing soluble TCRs.